You are currently viewing a new version of our website. To view the old version click .

Current Oncology, Volume 31, Issue 7

July 2024 - 43 articles

Cover Story: Chimeric antigen receptor (CAR) T-cell therapy has revolutionised the treatment landscape for patients with multiple myeloma and is likely to be approved in Canada soon. Idecabtagene vicleucel (Ide-cel) (ABECMA®) and Ciltacabtagene autoleucel (Cilta-cel) (CARVYKTI®) are the two CAR T-cell therapy products for patients with relapsed or refractory multiple myeloma commercially available in the US and Europe. Although they have shown unprecedented efficacy, their clinical and logistical limitations must also be acknowledged. Therefore, it is timely that we review the latest evidence on CAR T-cell therapy in multiple myeloma, with a focus on its relevance and impact in the Canadian setting. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (43)

  • Article
  • Open Access
5 Citations
2,546 Views
8 Pages

MRI-Targeted Prostate Fusion Biopsy: What Are We Missing outside the Target? Implications for Treatment Planning

  • Marco Oderda,
  • Alessandro Dematteis,
  • Giorgio Calleris,
  • Romain Diamand,
  • Marco Gatti,
  • Giancarlo Marra,
  • Gilles Adans-Dester,
  • Yazan Al Salhi,
  • Antonio Pastore and
  • Riccardo Faletti
  • + 1 author

22 July 2024

Introduction: This study aimed to evaluate the added diagnostic value of systematic biopsies (SBx) after magnetic resonance imaging (MRI)-targeted biopsies (TBx) and the presence of prostate cancer (PCa) outside MRI targets, in a prospective, contemp...

  • Case Report
  • Open Access
1 Citations
1,692 Views
10 Pages

Stereotactic Body Radiation Therapy for Symptomatic Pancreatic Insulinoma: Two-Case Report and Literature Review

  • Agnieszka Namysl-Kaletka,
  • Jerzy Wydmanski,
  • Iwona Debosz-Suwinska,
  • Malgorzata Kaszuba,
  • Dorota Gabrys,
  • Agata Roch-Zniszczol and
  • Daria Handkiewicz-Junak

22 July 2024

Insulinoma is the most common functional neuroendocrine tumor of the pancreas, with the main clinical symptom being hypoglycemia. The standard treatment is surgery, but some patients are not eligible for surgery, while in those operated on, the risk...

  • Article
  • Open Access
3 Citations
4,470 Views
18 Pages

The Effect of Oncology Nurse Navigation on Mental Health in Patients with Cancer in Taiwan: A Randomized Controlled Clinical Trial

  • Wei-Zhen Yu,
  • Hsin-Fang Wang,
  • Yen-Kuang Lin,
  • Yen-Lin Liu,
  • Yun Yen,
  • Jacqueline Whang-Peng,
  • Tsai-Wei Huang and
  • Hsiu-Ju Chang

20 July 2024

In this study, we investigated the prevalence of mental health problems among patients with cancer and whether oncology nurse navigation improved their mental health outcomes and medical experience. In this randomized controlled clinical trial, we re...

  • Article
  • Open Access
2 Citations
5,317 Views
12 Pages

Midazolam Indications and Dosing in Palliative Medicine: Results from a Multinational Survey

  • Morten Tranung,
  • Tora Skeidsvoll Solheim,
  • Erik Torbjørn Løhre,
  • Kristoffer Marsaa,
  • Dagny Faksvåg Haugen,
  • Barry Laird,
  • Morten Thronæs and
  • Michael Due Larsen

19 July 2024

Despite sparse evidence and limited guidance on indications, use, and dosing, midazolam is widely used in palliative care. We aimed to describe and compare the use of midazolam in three different countries to improve clinical practice in palliative c...

  • Article
  • Open Access
1 Citations
2,359 Views
14 Pages

19 July 2024

Objective: Intradural spinal metastases are considered rare. At present, limited information is available on incidence, surgical management, and outcomes. Methods: We conducted a retrospective patient chart review from 2002 to 2024, identifying all p...

  • Conference Report
  • Open Access
2 Citations
3,208 Views
16 Pages

Addressing the Rising Trend in Early-Age-Onset Cancers in Canada

  • Petra Wildgoose,
  • Filomena Servidio-Italiano,
  • Michael J. Raphael,
  • Monika Slovinec D’Angelo,
  • Cassandra Macaulay,
  • Shaqil Kassam,
  • Nancy Nixon,
  • José Perea,
  • Sarah Hamilton and
  • Ravi Ramjeesingh
  • + 5 authors

19 July 2024

A multi-disciplinary symposium on early-age onset cancer (EAOC) was held in October 2023 to explore challenges experienced by this rapidly growing population. A major outcome of the symposium was recognition of the remarkable similarities of EAOC pat...

  • Article
  • Open Access
1 Citations
2,405 Views
11 Pages

Confirmation of Recurrent Lung Cancer Following Resection Using Liquid Biopsy, a Proof-of-Concept Real-World Study

  • Julia R. Naso,
  • Stephen Yip,
  • Curtis Hughesman,
  • Barb Melosky,
  • Tanner Dowhy,
  • Melissa K. McConechy,
  • John C. English,
  • Penelope M. A. Brasher,
  • James Choi and
  • Kyle Grant
  • + 3 authors

17 July 2024

Appropriate management requires timely and accurate confirmation of non-small cell lung cancer (NSCLC) recurrence in patients who have had curative-intent surgical resection. We assessed the association between circulating tumor DNA (ctDNA) identifie...

  • Article
  • Open Access
6 Citations
2,881 Views
14 Pages

17 July 2024

Regular cervical screening can largely prevent the development of cervical cancer and innovative methods are needed to better engage people in screening. In Ontario, Canada, South Asian women have some of the lowest rates of screening in the province...

  • Communication
  • Open Access
5 Citations
2,877 Views
8 Pages

Ki-67 Labelling Index as a Predictor of Invasive Features in Thyroid Cancer: Retrospective Analysis and Implications

  • Raisa Chowdhury,
  • Raihanah Alsayegh,
  • Véronique-Isabelle Forest,
  • Marc Philippe Pusztaszeri,
  • Sabrina Daniela da Silva,
  • Livia Florianova and
  • Richard J. Payne

17 July 2024

Background: Ki-67 immunostaining is commonly used in neuroendocrine tumors to estimate the proliferative index and for grading. This study investigates its association with the invasiveness of follicular-derived thyroid carcinomas (TCs). Methods: A r...

  • Guidelines
  • Open Access
5 Citations
6,494 Views
8 Pages

Canadian Consensus for Treatment of BRAF V600E Mutated Pediatric and AYA Gliomas

  • Craig Erker,
  • Magimairajan Issai Vanan,
  • Valérie Larouche,
  • Liana Nobre,
  • Chantel Cacciotti,
  • Stéphanie Vairy,
  • Shayna Zelcer,
  • Adam Fleming,
  • Eric Bouffet and
  • Nada Jabado
  • + 18 authors

16 July 2024

Background: The treatment of BRAF V600E gliomas with BRAF inhibitors (BRAFis) and MEK inhibitors (MEKis) has been increasingly integrated into clinical practice for pediatric low-grade gliomas (PLGGs) and pediatric high-grade gliomas (HGGs). However,...

of 5

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729